drugset / Trial / NCT02431221

Efficacy, Safety, and Tolerability of Perhexiline in Subjects With Hypertrophic Cardiomyopathy and Heart Failure

NCT02431221 ↗

Phase 3 Withdrawn Heart Metabolics Limited
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A Study on the Efficacy, Safety, and Tolerability of Perhexiline maleate in Subjects with Hypertrophic Cardiomyopathy and Moderate-To-Severe Heart Failure

Timeline

Start
—
Primary completion
2017-07
Completion
—

Outcome

Outcome not reported

Stopped: “Lack of efficacy in a preceding study.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Perhexiline Small molecule 200 mg Oral